Optimization of regions of interest sampling strategies for proton density fat-fraction MRI of hepatic steatosis before liver transplantation in ex vivo livers
- PMID: 40028590
- PMCID: PMC11872435
- DOI: 10.1016/j.heliyon.2024.e40146
Optimization of regions of interest sampling strategies for proton density fat-fraction MRI of hepatic steatosis before liver transplantation in ex vivo livers
Abstract
Objectives: The quantity of regions of interest (ROIs) constitutes the primary determinant of the time investment in image analysis. In the context of proton density fat-fraction (PDFF) magnetic resonance imaging (MRI) conducted on liver grafts in ex vivo conditions, this research systematically examines various ROI sampling strategies. The findings of this study furnish essential insights, offering a foundation for optimizing time efficiency while ensuring precise assessment of hepatic steatosis before the crucial process of liver transplantation.
Methods: This was a retrospective analysis of a prospective study and included 35 liver grafts with histopathological steatosis that underwent 3T PDFF MRI in ex vivo. One ROI of 1 cm2 was selected for each hepatic segment, and any combination of ROIs in 1-8 liver segments was used, resulting in 511 combinations. Using intraclass correlation coefficients (ICCs) and Bland-Altman analyses, the PDFFs of all these combinations were compared with the 9-ROI average PDFF. There was a moderate correlation between the average PDFF and the histological findings (R = 0.47, P<0.01).
Results: The average 9-ROI PDFF of all liver grafts was 4.07 ± 4.35 % (0.870-20.904). All strategies with ≥5 ROIs had intraclass correlation coefficient (ICC) ≥ 0.995 and absolute limits of agreement (|LOA|)≤ 1.5 %. Overall, 54 of 84 (67.5 %) 3-ROI sampling strategy had ICC ≥0.995, and 70 of 84 (70 %) had |LOA|≤ 1.5 %. A total of 111 of 126 (88.1 %) 4-ROI sampling strategy had ICC ≥0.995, and 125 of 126 (99.2 %) had |LOA| ≤ 1.5 %.
Conclusions: The employment of the 5-ROI sampling strategy proves instrumental in both time conservation and precise assessment of hepatic steatosis within liver grafts during the ex vivo phase preceding liver transplantation.
Keywords: Hepatic steatosis; Liver transplantation; Proton density fat fraction; Sampling strategy.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures





References
-
- Linares I., Hamar M., Selzner N., Selzner M. Steatosis in liver transplantation: current limitations and future strategies. Transplantation. 2019;103:78–90. - PubMed
-
- Byun J., Lee S.S., Sung Y.S., Shin Y., Yun J., Kim H.S., Yu E.S., Lee S.G., Lee M.G. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard. Eur. Radiol. 2019;29:4427–4435. - PubMed
-
- Chu M.J., Dare A.J., Phillips A.R., Bartlett A.S. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J. Gastrointest. Surg. 2015;19:1713–1724. - PubMed
-
- Flechtenmacher C., Schirmacher P., Schemmer P. Donor liver histology--a valuable tool in graft selection. Langenbeck's Arch. Surg. 2015;400:551–557. - PubMed
-
- Spitzer A.L., Lao O.B., Dick A.A., Bakthavatsalam R., Halldorson J.B., Yeh M.M., Upton M.P., Reyes J.D., Perkins J.D. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transplant. 2010;16:874–884. - PubMed
LinkOut - more resources
Full Text Sources